Home  »  Finance   »  AIkido Pharma Inc. (NASDAQ: AIKI) Metrics That Mat...

AIkido Pharma Inc. (NASDAQ: AIKI) Metrics That Matter Right Now

AIkido Pharma Inc. (NASDAQ:AIKI) shares, rose in value on Thursday, 05/12/22, with the stock price down by -2.15% to the previous day’s close as strong demand from buyers drove the stock to $0.30.

Actively observing the price movement in the last trading, the stock closed the session at $0.31, falling within a range of $0.2943 and $0.31. The value of beta (5-year monthly) was 1.45. Referring to stock’s 52-week performance, its high was $1.21, and the low was $0.29. On the whole, AIKI has fluctuated by -19.92% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


With the market capitalization of AIkido Pharma Inc. currently standing at about $26.03 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 23, 2022 – Mar 28, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.01, which is expected to increase to $0 for fiscal year -$0.08 and then to about -$0.09 by fiscal year 2022.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AIKI’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AIKI currently trading nearly -12.99% and -23.21% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.12, while the 7-day volatility ratio is showing 13.16% which for the 30-day chart, stands at 11.76%. Furthermore, AIkido Pharma Inc. (AIKI)’s beta value is 1.56, and its average true range (ATR) is 0.05.

Data on historical trading for AIkido Pharma Inc. (NASDAQ:AIKI) indicates that the trading volumes over the past 10 days have averaged 4.16 million and over the past 3 months, they’ve averaged 1.63 million. According to company’s latest data on outstanding shares, there are 89.76 million shares outstanding.

Nearly 0.20% of AIkido Pharma Inc.’s shares belong to company insiders and institutional investors own 8.90% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.69 million shares as on Feb 14, 2022, resulting in a short ratio of 0.64. According to the data, the short interest in AIkido Pharma Inc. (AIKI) stood at 0.77% of shares outstanding as of Feb 14, 2022; the number of short shares registered in Jan 13, 2022 reached 0.4 million. The stock has fallen by -48.84% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AIKI stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam